Literature DB >> 2968404

Synthesis and regulation of complement protein factor H in human skin fibroblasts.

Y Katz1, R C Strunk.   

Abstract

The alternative pathway of C activation is Ag-independent and forms a first line of defense against infection before immune response. The C3 convertase, C3bBb, formed during activation of the alternative pathway is tightly regulated, with destabilization produced by factor H. Using metabolic labeling with [35S]methionine, immunoprecipitation, and SDS-PAGE, we demonstrated that human skin fibroblasts synthesized and secreted factor H protein. Two forms of the protein were identified, the approximately 160-kDa form seen more prominently in serum and a 45-kDa form that has also been identified in serum. The cells contained two forms of factor H mRNA, 4.4 and 1.8 kb. IFN-gamma increased factor H protein synthesis and mRNA content. No effect was observed with LPS. Neither HepG2 cells or human peripheral blood monocytes synthesized factor H protein or contained factor H mRNA.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2968404

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  Different regulation of factor H and FHL-1/reconectin by inflammatory mediators and expression of the two proteins in rheumatoid arthritis (RA).

Authors:  M A Friese; J Hellwage; T S Jokiranta; S Meri; H J Müller-Quernheim; H H Peter; H Eibel; P F Zipfel
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

2.  Enhanced bacteremia in human factor H transgenic rats infected by Neisseria meningitidis.

Authors:  David M Vu; Jutamas Shaughnessy; Lisa A Lewis; Sanjay Ram; Peter A Rice; Dan M Granoff
Journal:  Infect Immun       Date:  2011-11-21       Impact factor: 3.441

Review 3.  Complement biosynthesis by mononuclear phagocytes.

Authors:  A R McPhaden; K Whaley
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

4.  The molecular basis of hereditary complement factor I deficiency.

Authors:  T J Vyse; B J Morley; I Bartok; E L Theodoridis; K A Davies; A D Webster; M J Walport
Journal:  J Clin Invest       Date:  1996-02-15       Impact factor: 14.808

5.  Cross-Talk between the Complement Pathway and the Contact Activation System of Coagulation: Activated Factor XI Neutralizes Complement Factor H.

Authors:  Cristina Puy; Jiaqing Pang; Stéphanie E Reitsma; Christina U Lorentz; Erik I Tucker; David Gailani; András Gruber; Florea Lupu; Owen J T McCarty
Journal:  J Immunol       Date:  2021-04-15       Impact factor: 5.422

6.  Interferon-induced transcriptional and post-transcriptional modulation of factor H and C4 binding-protein synthesis in human monocytes.

Authors:  D F Lappin; K Whaley
Journal:  Biochem J       Date:  1990-11-01       Impact factor: 3.857

7.  Prevalence of the 1.8 kb complement factor H mRNA in human lung.

Authors:  M J Demares; C Davrinche
Journal:  Immunology       Date:  1990-06       Impact factor: 7.397

Review 8.  Complement system in dermatological diseases - fire under the skin.

Authors:  Jaana Panelius; Seppo Meri
Journal:  Front Med (Lausanne)       Date:  2015-01-29

9.  Factor h: a complement regulator in health and disease, and a mediator of cellular interactions.

Authors:  Anne Kopp; Mario Hebecker; Eliška Svobodová; Mihály Józsi
Journal:  Biomolecules       Date:  2012-02-07

Review 10.  Complement factor H in host defense and immune evasion.

Authors:  Raffaella Parente; Simon J Clark; Antonio Inforzato; Anthony J Day
Journal:  Cell Mol Life Sci       Date:  2016-12-10       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.